---
$id: https://graph.org.ai/products/commodity/51171975
$type: Product
source: UNSPSC
code: "51171975"
title: "Miglustat"
class: "51171900"
classTitle: "Antiulcer and related gastrointestinal GI drugs"
family: "51170000"
familyTitle: "Drugs affecting the gastrointestinal system"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Miglustat

**UNSPSC Code**: 51171975
**Class**: [Antiulcer and related gastrointestinal GI drugs](Antiulcer and related gastrointestinal GI drugs.mdx)
**Family**: [Drugs affecting the gastrointestinal system](../Drugs affecting the gastrointestinal system.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a glucosidase inhibitor with the molecular formula C10H21NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier ADN3S497AZ, chemically known as 3,4,5-piperidinetriol, 1-butyl-2-(hydroxymethyl)-, (2r,3r,4r,5s)- but generally known as miglustat, which bears US NIH Compound Identifier 51634. European Medicines Agency schedules Miglustat in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB20049. The term MIGLUSTAT is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16., No. 1.2002, List 47). World Health Organization schedules miglustat in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule Miglustat under HS 29333999 and SITC 51574. As of Q4 2014, MIGLUSTAT remains the US FDA Preferred Term for this commodity. Miglustat bears US NLM identifiers UMLS ID C1321596 and NCI Concept Code C1222. SMILES: CCCCN1C[C@@H]([C@H]([C@@H]([C@H]1CO)O)O)O.

